 Mehmet Kocak
Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 3 | 2019 | 222 | 1.280 |
Why?
| | Magnetic Resonance Imaging | 9 | 2020 | 1244 | 1.090 |
Why?
| | Brain Mapping | 6 | 2021 | 196 | 0.950 |
Why?
| | Blood Glucose | 2 | 2020 | 136 | 0.950 |
Why?
| | Neuregulins | 1 | 2019 | 1 | 0.830 |
Why?
| | Headache | 1 | 2019 | 51 | 0.790 |
Why?
| | Mean Platelet Volume | 1 | 2018 | 1 | 0.770 |
Why?
| | Cerebral Hemorrhage | 4 | 2021 | 132 | 0.760 |
Why?
| | Diabetic Nephropathies | 1 | 2018 | 39 | 0.740 |
Why?
| | Lymphocytes | 1 | 2018 | 116 | 0.730 |
Why?
| | Circle of Willis | 1 | 2017 | 8 | 0.690 |
Why?
| | Sclerosis | 1 | 2017 | 64 | 0.670 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2017 | 48 | 0.650 |
Why?
| | Temporal Lobe | 1 | 2017 | 112 | 0.630 |
Why?
| | Thalamus | 4 | 2021 | 25 | 0.610 |
Why?
| | Image Enhancement | 2 | 2020 | 71 | 0.580 |
Why?
| | Diffusion Tensor Imaging | 3 | 2021 | 77 | 0.540 |
Why?
| | Brain | 6 | 2021 | 1574 | 0.500 |
Why?
| | Humans | 39 | 2021 | 30741 | 0.490 |
Why?
| | Adult | 20 | 2021 | 9760 | 0.490 |
Why?
| | Middle Aged | 20 | 2020 | 11256 | 0.480 |
Why?
| | Female | 25 | 2021 | 18107 | 0.480 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2010 | 92 | 0.470 |
Why?
| | Male | 24 | 2021 | 17552 | 0.430 |
Why?
| | Evoked Potentials, Motor | 1 | 2009 | 10 | 0.390 |
Why?
| | Brain Ischemia | 2 | 2021 | 117 | 0.390 |
Why?
| | Diagnostic Imaging | 1 | 2010 | 95 | 0.390 |
Why?
| | Motor Cortex | 1 | 2009 | 17 | 0.390 |
Why?
| | Diffusion Magnetic Resonance Imaging | 4 | 2021 | 119 | 0.380 |
Why?
| | Neurodegenerative Diseases | 1 | 2010 | 112 | 0.370 |
Why?
| | Brain Diseases | 1 | 2009 | 90 | 0.370 |
Why?
| | Young Adult | 6 | 2021 | 2249 | 0.350 |
Why?
| | Graft Rejection | 2 | 2018 | 85 | 0.340 |
Why?
| | Aged | 12 | 2020 | 10156 | 0.330 |
Why?
| | Contrast Media | 3 | 2020 | 147 | 0.320 |
Why?
| | Cross-Sectional Studies | 3 | 2019 | 957 | 0.320 |
Why?
| | Liver Transplantation | 2 | 2018 | 110 | 0.320 |
Why?
| | Auditory Cortex | 1 | 2005 | 3 | 0.310 |
Why?
| | Language | 1 | 2005 | 78 | 0.290 |
Why?
| | Sex Characteristics | 1 | 2005 | 126 | 0.280 |
Why?
| | Magnetic Resonance Angiography | 2 | 2008 | 51 | 0.250 |
Why?
| | Brain Neoplasms | 2 | 2021 | 185 | 0.250 |
Why?
| | Postoperative Complications | 3 | 2020 | 1084 | 0.250 |
Why?
| | Risk Factors | 6 | 2020 | 2611 | 0.240 |
Why?
| | Radiology | 1 | 2021 | 22 | 0.230 |
Why?
| | Patient Care Planning | 1 | 2001 | 58 | 0.230 |
Why?
| | Encephalocele | 1 | 2021 | 24 | 0.230 |
Why?
| | Adenolymphoma | 1 | 2020 | 4 | 0.220 |
Why?
| | Adenoma, Pleomorphic | 1 | 2020 | 6 | 0.220 |
Why?
| | Carcinoma, Renal Cell | 1 | 2001 | 77 | 0.220 |
Why?
| | Facial Nerve | 1 | 2020 | 13 | 0.220 |
Why?
| | Parotid Neoplasms | 1 | 2020 | 12 | 0.220 |
Why?
| | Parotid Gland | 1 | 2020 | 18 | 0.220 |
Why?
| | Digestive System Surgical Procedures | 1 | 2020 | 27 | 0.220 |
Why?
| | Dissection | 1 | 2020 | 29 | 0.220 |
Why?
| | Glioma | 1 | 2021 | 58 | 0.210 |
Why?
| | Signal-To-Noise Ratio | 1 | 2020 | 6 | 0.210 |
Why?
| | Nerve Net | 1 | 2021 | 54 | 0.210 |
Why?
| | Kidney Neoplasms | 1 | 2001 | 110 | 0.210 |
Why?
| | Gray Matter | 1 | 2021 | 55 | 0.210 |
Why?
| | Hyperglycemia | 1 | 2020 | 47 | 0.210 |
Why?
| | Case-Control Studies | 2 | 2019 | 694 | 0.210 |
Why?
| | Artifacts | 1 | 2020 | 37 | 0.210 |
Why?
| | White Matter | 2 | 2019 | 124 | 0.210 |
Why?
| | Hernia | 1 | 2019 | 8 | 0.200 |
Why?
| | Fasting | 1 | 2019 | 25 | 0.200 |
Why?
| | Neuroma, Acoustic | 1 | 2019 | 10 | 0.200 |
Why?
| | Kidney | 1 | 2001 | 209 | 0.200 |
Why?
| | Sarcoidosis | 1 | 2019 | 15 | 0.200 |
Why?
| | Emergencies | 1 | 2019 | 42 | 0.200 |
Why?
| | Brain Edema | 1 | 2019 | 30 | 0.200 |
Why?
| | Liver Neoplasms | 2 | 2018 | 128 | 0.200 |
Why?
| | Central Nervous System Diseases | 1 | 2019 | 23 | 0.200 |
Why?
| | Diabetes, Gestational | 1 | 2019 | 7 | 0.200 |
Why?
| | Movement | 1 | 2020 | 167 | 0.200 |
Why?
| | Acute Disease | 2 | 2019 | 272 | 0.200 |
Why?
| | Spinal Cord Diseases | 1 | 2019 | 50 | 0.190 |
Why?
| | Turkey | 1 | 2018 | 5 | 0.190 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2019 | 24 | 0.190 |
Why?
| | Stomach | 1 | 2018 | 19 | 0.190 |
Why?
| | Lymphocyte Count | 1 | 2018 | 35 | 0.190 |
Why?
| | Cerebral Cortex | 1 | 2021 | 203 | 0.190 |
Why?
| | Recovery of Function | 1 | 2020 | 309 | 0.190 |
Why?
| | Obesity, Abdominal | 1 | 2018 | 22 | 0.190 |
Why?
| | Brain Abscess | 1 | 2018 | 6 | 0.190 |
Why?
| | Adiposity | 1 | 2019 | 51 | 0.190 |
Why?
| | Cystic Fibrosis | 1 | 2018 | 14 | 0.190 |
Why?
| | Pediatric Obesity | 1 | 2019 | 38 | 0.190 |
Why?
| | Cerebral Angiography | 1 | 2018 | 72 | 0.190 |
Why?
| | Intracranial Pressure | 1 | 2018 | 24 | 0.180 |
Why?
| | Intra-Abdominal Fat | 1 | 2018 | 47 | 0.180 |
Why?
| | Weight Gain | 1 | 2019 | 68 | 0.180 |
Why?
| | Nerve Fibers | 1 | 2018 | 17 | 0.180 |
Why?
| | Cerebrovascular Disorders | 1 | 2019 | 124 | 0.180 |
Why?
| | Walking | 1 | 2020 | 241 | 0.180 |
Why?
| | Child Development | 1 | 2019 | 80 | 0.180 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2018 | 46 | 0.180 |
Why?
| | Biliary Tract | 1 | 2017 | 3 | 0.180 |
Why?
| | Cholestasis, Extrahepatic | 1 | 2017 | 3 | 0.180 |
Why?
| | Leukoencephalopathies | 1 | 2017 | 9 | 0.170 |
Why?
| | Cysts | 1 | 2017 | 21 | 0.170 |
Why?
| | Spinal Diseases | 1 | 2019 | 152 | 0.170 |
Why?
| | Constriction, Pathologic | 1 | 2017 | 38 | 0.170 |
Why?
| | Pregnancy | 1 | 2019 | 452 | 0.170 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2018 | 230 | 0.170 |
Why?
| | Emergency Service, Hospital | 1 | 2019 | 167 | 0.170 |
Why?
| | Anastomosis, Surgical | 1 | 2017 | 56 | 0.170 |
Why?
| | Adolescent | 4 | 2020 | 2627 | 0.170 |
Why?
| | Image Processing, Computer-Assisted | 4 | 2018 | 233 | 0.170 |
Why?
| | Epithalamus | 1 | 2016 | 3 | 0.170 |
Why?
| | Afferent Pathways | 1 | 2016 | 7 | 0.170 |
Why?
| | Calcinosis | 1 | 2017 | 53 | 0.170 |
Why?
| | Kidney Diseases | 1 | 2018 | 143 | 0.170 |
Why?
| | Functional Laterality | 1 | 2017 | 95 | 0.160 |
Why?
| | Tomography, X-Ray Computed | 5 | 2018 | 876 | 0.160 |
Why?
| | Breast Neoplasms | 1 | 2020 | 440 | 0.150 |
Why?
| | Prospective Studies | 5 | 2021 | 1891 | 0.150 |
Why?
| | Cervical Vertebrae | 1 | 2019 | 330 | 0.150 |
Why?
| | Radiopharmaceuticals | 2 | 2010 | 64 | 0.150 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 321 | 0.150 |
Why?
| | Child | 3 | 2021 | 1547 | 0.140 |
Why?
| | Stroke | 1 | 2018 | 345 | 0.140 |
Why?
| | Dominance, Cerebral | 2 | 2005 | 24 | 0.140 |
Why?
| | Retrospective Studies | 6 | 2021 | 3456 | 0.140 |
Why?
| | Corpus Callosum | 2 | 2019 | 18 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 3 | 2006 | 232 | 0.120 |
Why?
| | Aged, 80 and over | 5 | 2020 | 5172 | 0.120 |
Why?
| | Prognosis | 3 | 2020 | 1045 | 0.110 |
Why?
| | Sensitivity and Specificity | 3 | 2009 | 594 | 0.110 |
Why?
| | Parkinson Disease | 2 | 2018 | 1136 | 0.110 |
Why?
| | Dementia, Vascular | 1 | 2010 | 42 | 0.100 |
Why?
| | Follow-Up Studies | 4 | 2020 | 2046 | 0.100 |
Why?
| | Neuroradiography | 1 | 2009 | 3 | 0.100 |
Why?
| | Time Factors | 3 | 2020 | 1911 | 0.100 |
Why?
| | Aging | 1 | 2019 | 1551 | 0.100 |
Why?
| | Diagnosis, Differential | 3 | 2019 | 469 | 0.100 |
Why?
| | Subclavian Artery | 1 | 2008 | 6 | 0.100 |
Why?
| | Vertebral Artery | 1 | 2008 | 8 | 0.100 |
Why?
| | Pediatrics | 1 | 2009 | 48 | 0.100 |
Why?
| | Echo-Planar Imaging | 2 | 2005 | 5 | 0.090 |
Why?
| | Reference Values | 1 | 2009 | 258 | 0.090 |
Why?
| | Thallium Radioisotopes | 3 | 1999 | 6 | 0.090 |
Why?
| | Technetium Tc 99m Sestamibi | 3 | 1999 | 12 | 0.090 |
Why?
| | Organotechnetium Compounds | 3 | 1999 | 9 | 0.090 |
Why?
| | Pilot Projects | 1 | 2009 | 440 | 0.090 |
Why?
| | Graft Survival | 2 | 2018 | 111 | 0.090 |
Why?
| | Survival Rate | 2 | 2018 | 478 | 0.080 |
Why?
| | Neural Pathways | 1 | 2006 | 84 | 0.080 |
Why?
| | Body Mass Index | 2 | 2019 | 438 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2009 | 875 | 0.080 |
Why?
| | Longitudinal Studies | 2 | 2020 | 1432 | 0.070 |
Why?
| | Paranasal Sinus Diseases | 1 | 2003 | 15 | 0.070 |
Why?
| | Aphasia, Broca | 1 | 2003 | 2 | 0.070 |
Why?
| | Frontal Sinus | 1 | 2003 | 13 | 0.060 |
Why?
| | Regional Blood Flow | 1 | 2003 | 18 | 0.060 |
Why?
| | Nerve Regeneration | 1 | 2003 | 17 | 0.060 |
Why?
| | Astrocytoma | 1 | 2003 | 37 | 0.060 |
Why?
| | Frontal Lobe | 1 | 2003 | 87 | 0.060 |
Why?
| | Neuronal Plasticity | 1 | 2003 | 50 | 0.060 |
Why?
| | Child, Preschool | 2 | 2019 | 803 | 0.060 |
Why?
| | Iliac Artery | 1 | 2001 | 8 | 0.060 |
Why?
| | Renal Artery | 1 | 2001 | 10 | 0.060 |
Why?
| | Petrous Bone | 1 | 2021 | 7 | 0.060 |
Why?
| | Cerebrospinal Fluid Otorrhea | 1 | 2021 | 6 | 0.060 |
Why?
| | Pelvis | 1 | 2001 | 26 | 0.060 |
Why?
| | Prevalence | 2 | 2018 | 546 | 0.060 |
Why?
| | Multimodal Imaging | 1 | 2021 | 30 | 0.050 |
Why?
| | Fatigue | 1 | 2020 | 67 | 0.050 |
Why?
| | Caudate Nucleus | 1 | 2019 | 19 | 0.050 |
Why?
| | Healthy Volunteers | 1 | 2019 | 49 | 0.050 |
Why?
| | Globus Pallidus | 1 | 2019 | 31 | 0.050 |
Why?
| | Carcinoma, Medullary | 1 | 1999 | 4 | 0.050 |
Why?
| | Radionuclide Imaging | 5 | 1999 | 58 | 0.050 |
Why?
| | Exercise Therapy | 1 | 2020 | 116 | 0.050 |
Why?
| | Tennessee | 1 | 2018 | 9 | 0.050 |
Why?
| | Gastrointestinal Transit | 1 | 1998 | 14 | 0.050 |
Why?
| | Intestinal Diseases | 1 | 2018 | 11 | 0.050 |
Why?
| | Ileum | 1 | 2018 | 31 | 0.050 |
Why?
| | Renal Replacement Therapy | 1 | 2018 | 23 | 0.050 |
Why?
| | Sex Factors | 1 | 2021 | 535 | 0.050 |
Why?
| | Bacterial Translocation | 1 | 1998 | 35 | 0.050 |
Why?
| | Area Under Curve | 1 | 2018 | 78 | 0.050 |
Why?
| | Thyroid Neoplasms | 1 | 1999 | 52 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 631 | 0.050 |
Why?
| | ROC Curve | 1 | 2018 | 155 | 0.050 |
Why?
| | Pseudomonas Infections | 1 | 2018 | 60 | 0.040 |
Why?
| | Intestines | 1 | 1998 | 108 | 0.040 |
Why?
| | Diabetes Mellitus | 1 | 2018 | 140 | 0.040 |
Why?
| | Hospitalization | 1 | 2020 | 344 | 0.040 |
Why?
| | Smoking | 1 | 2018 | 197 | 0.040 |
Why?
| | Preoperative Care | 1 | 2018 | 149 | 0.040 |
Why?
| | Habenula | 1 | 2016 | 3 | 0.040 |
Why?
| | Infant | 1 | 2019 | 660 | 0.040 |
Why?
| | Mothers | 1 | 2019 | 178 | 0.040 |
Why?
| | Infant, Newborn | 1 | 2019 | 751 | 0.040 |
Why?
| | Length of Stay | 1 | 2018 | 371 | 0.040 |
Why?
| | Succimer | 1 | 1995 | 1 | 0.040 |
Why?
| | Technetium Tc 99m Medronate | 1 | 1995 | 3 | 0.040 |
Why?
| | Hemangioma | 1 | 1995 | 6 | 0.040 |
Why?
| | Exercise | 1 | 2020 | 431 | 0.040 |
Why?
| | Deep Brain Stimulation | 1 | 2016 | 65 | 0.040 |
Why?
| | Thymoma | 1 | 1995 | 15 | 0.040 |
Why?
| | Thymus Neoplasms | 1 | 1995 | 14 | 0.040 |
Why?
| | Parathyroid Glands | 1 | 1995 | 9 | 0.040 |
Why?
| | Thymus Gland | 1 | 1995 | 28 | 0.040 |
Why?
| | Quality of Life | 1 | 2020 | 636 | 0.040 |
Why?
| | Risk Assessment | 1 | 2018 | 804 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 403 | 0.040 |
Why?
| | Sugar Acids | 1 | 1994 | 2 | 0.040 |
Why?
| | Behcet Syndrome | 1 | 1994 | 4 | 0.030 |
Why?
| | Cardiovascular Diseases | 1 | 2018 | 391 | 0.030 |
Why?
| | Uveitis | 1 | 1994 | 8 | 0.030 |
Why?
| | United States | 1 | 2019 | 2467 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2020 | 3850 | 0.030 |
Why?
| | Arteritis | 1 | 2008 | 3 | 0.020 |
Why?
| | Aneurysm | 1 | 2008 | 15 | 0.020 |
Why?
| | Aneurysm, Dissecting | 1 | 2008 | 23 | 0.020 |
Why?
| | Technetium Tc 99m Dimercaptosuccinic Acid | 2 | 1999 | 2 | 0.020 |
Why?
| | Medical Illustration | 1 | 2006 | 19 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2003 | 62 | 0.020 |
Why?
| | Research Design | 1 | 2003 | 230 | 0.010 |
Why?
| | Organophosphorus Compounds | 1 | 1999 | 7 | 0.010 |
Why?
| | Neurons | 1 | 2003 | 397 | 0.010 |
Why?
| | Calcitonin | 1 | 1999 | 16 | 0.010 |
Why?
| | Parasympathomimetics | 1 | 1998 | 4 | 0.010 |
Why?
| | Parenteral Nutrition, Total | 1 | 1998 | 4 | 0.010 |
Why?
| | Peristalsis | 1 | 1998 | 11 | 0.010 |
Why?
| | Neostigmine | 1 | 1998 | 6 | 0.010 |
Why?
| | Rats, Wistar | 1 | 1998 | 69 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 1999 | 111 | 0.010 |
Why?
| | Soft Tissue Neoplasms | 1 | 1999 | 44 | 0.010 |
Why?
| | Morphine | 1 | 1998 | 80 | 0.010 |
Why?
| | Bone Neoplasms | 1 | 1999 | 115 | 0.010 |
Why?
| | Rats | 1 | 1998 | 954 | 0.010 |
Why?
| | Parathyroid Neoplasms | 1 | 1995 | 5 | 0.010 |
Why?
| | False Positive Reactions | 1 | 1995 | 40 | 0.010 |
Why?
| | Ultrasonography | 1 | 1995 | 204 | 0.010 |
Why?
| | Adenoma | 1 | 1995 | 57 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 1999 | 753 | 0.010 |
Why?
| | Animals | 1 | 1998 | 5221 | 0.010 |
Why?
|
|
Kocak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|